Jubilant HollisterStier LLC is a prominent integrated contract development and manufacturing organization (CDMO) providing specialized services for sterile injectable, ophthalmic, and otic products. They are also a well-established leader in the manufacturing of allergenic extracts. With facilities in the U.S. and Canada, the company serves pharmaceutical and biopharmaceutical clients globally, offering a full range of services from clinical to commercial scale manufacturing, including aseptic filling, lyophilization, and packaging. They are a subsidiary of Jubilant Pharma Limited, which is part of the larger Jubilant Pharmova Limited group.
The Spokane headquarters serves as a major cGMP manufacturing site for sterile injectables and allergenic extracts, and houses corporate leadership, R&D, quality assurance, and administrative functions for U.S. operations.
The facility boasts state-of-the-art aseptic filling lines, extensive lyophilization (freeze-drying) capacity, dedicated areas for allergenic product manufacturing, and advanced quality control laboratories.
The work culture emphasizes cGMP compliance, precision, quality, safety, and continuous improvement, typical of a highly regulated pharmaceutical manufacturing environment. Collaboration and technical expertise are highly valued.
This site is a cornerstone of Jubilant Pharma's North American operations, critical for both its proprietary allergenic extract business and its contract manufacturing services for global pharmaceutical clients. It has a long-standing reputation for quality and reliability in sterile manufacturing.
Jubilant HollisterStier LLC operates key manufacturing facilities in the USA (Spokane, WA) and Canada (Montreal, QC). Through these sites, it provides global contract manufacturing services for sterile injectables, liquids, and lyophilized products. It is also a leading manufacturer of allergenic extracts distributed worldwide. Its products and services reach patients and pharmaceutical partners across North America, Europe, Asia, and other international markets, supported by the extensive global network of its parent company, Jubilant Pharmova Ltd.
3525 N Regal St
Spokane
WA
USA
Address: 16750 Trans-Canada Hwy, Kirkland, QC H9H 4J4, Canada
The Montreal-area facility provides strategic manufacturing capacity in Canada, serving both North American and international markets. It enhances business continuity, offers access to a skilled pharmaceutical workforce in the Montreal biotech hub, and supports global supply chains.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Jubilant HollisterStier LLC' leadership includes:
Jubilant HollisterStier LLC has been backed by several prominent investors over the years, including:
Jubilant HollisterStier has experienced key leadership changes over the past year, including the appointment of a new President and a new SVP & Chief Commercial Officer, aimed at driving growth and operational excellence.
Discover the tools Jubilant HollisterStier LLC uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Jubilant HollisterStier LLC likely utilizes common corporate email formats. While specific patterns can vary, structures based on employee names are prevalent in organizations of this type. The most common format is often [first_initial][last] or [first].[last] @jublhs.com.
[first].[last]@jublhs.com or [first_initial][last]@jublhs.com
Format
jane.doe@jublhs.com
Example
85%
Success rate
Jubilant Pharmova / Financial News Outlets • February 20, 2024
Jubilant Pharmova, parent company of Jubilant HollisterStier, reported strong performance in its CDMO segment for Q3 FY24, particularly in sterile injectables. This reflects increased demand and operational efficiencies at facilities like those managed by Jubilant HollisterStier....more
jublhs.com • October 17, 2023
Jubilant HollisterStier announced the successful completion of a routine U.S. Food and Drug Administration (FDA) inspection at its sterile manufacturing facility in Montreal, Canada, reaffirming its commitment to cGMP quality and compliance standards....more
jublhs.com • May 2, 2023
Jubilant HollisterStier is undertaking a Phase II expansion of its sterile fill and finish manufacturing capacity at its Spokane, Washington facility. This expansion aims to meet the growing demand for its contract manufacturing services from global pharmaceutical partners....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Jubilant HollisterStier LLC, are just a search away.